Postcoital interceptive activity of Wrightia tinctoria in Sprague-Dawley rats: a preliminary study

Contraception

Volumn 78, Issue 3, 2008, Pages 266-270

  Keshri, Govind ^a   Kumar, Sudhir ^a   Kulshreshtha, Dinesh Kumar ^a   Rajendran, Siron Mani ^a   Singh, Man Mohan ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Contraceptive; Early postimplantation; Estrogen agonistic activity; Implantation; Rat; Stem bark; Wrightia tinctoria

Indexed keywords

ALCOHOL; BUTANOL; CHLOROFORM; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; HEXANE; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER; WRIGHTIA TINCTORIA EXTRACT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; BARK; BIOASSAY; COITUS; CONTRACEPTION; CONTROLLED STUDY; DRUG SOLUBILITY; FEMALE; MEDICINAL PLANT; NIDATION; NONHUMAN; OVARIECTOMY; PREIMPLANTATION EMBRYO; RAT; SPERM; SPRAGUE DAWLEY RAT; UTERUS WEIGHT; VAGINA SMEAR; WRIGHTIA TINCTORIA;

ANIMALS; APOCYNACEAE; CONTRACEPTIVES, POSTCOITAL; FEMALE; MALE; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 48649110819     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.03.016     Document Type: Article

References (35)

1. Reddy Y.S.R., Venkatesh S., Ravichandran T., Subburaju T., and Suresh B. Pharmacognostical studies on Wrightia tinctoria bark. Pharmaceut Biol 37 (1999) 291-295
2. Joshi M.C., Patel M.B., and Mehta P.J. Some folk medicines of drugs. Bull Med Ethnobot Res 1 (1980) 8-24
3. Shah G.L., and Gopal G.V. Ethnomedical notes from the tribal inhabitants of the north Gujarat (India). J Eco Tox Bot 6 (1988) 193-221
4. Reddy M.B., Reddy K.R., and Reddy M.N. A survey of plant crude drugs of Ananthapur District, Andhra Pradesh, India. Int J Crude Drug Res 27 (1989) 145-155
5. Singh V.P., Sharma S.K., and Kare V.S. Medicinal plants from Ujjain District, Madhya Pradesh: Part 2. Indian Drugs 17 (1980) 7-12
6. Siddiqui M.B., and Hussain W. Traditional antidotes of snake poison. Fitoterapia 61 (1990) 41-44
7. Chopra R.N., Nayar S.L., and Chopra I.C. Wrightia in glossary of Indian medicinal plants (1956), Publications and Information Directorate, CSIR, New Delhi 259
8. Grady D., Grebretsadik T., Ernestwr V., and Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85 (1995) 304-313
9. Beresford S.A., Weiss N.S., Voigt L.F., and McKnight B. Risk of endometrial cancer in relation use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 349 (1997) 458-461
10. Riggs L., and Hartmann L.C. Selective estrogen receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 348 (2003) 618-629
11. Delmas P.D. Treatment of post-menopausal osteoporosis. Lancet 359 (2002) 2018-2026
12. Singh M.M., Chowdhury S.R., Kulshreshtha D.K., and Kamboj V.P. Antigestagenic activity of Ixora finlaysoniana in rats. Contraception 48 (1993) 178-191
13. WHO protocol of MB-70: a method for detecting estrogenicity in plant extracts administered orally in the rats, 9856F (1983), WHO, Geneva
14. Singh M.M., Wadhwa V., Gupta D.N., Pal R., Khanna N.M., and Kamboj V.P. Post-coital contraceptive and hormonal profile of Lepidium capitatum. Planta Medica 50 (1984) 154-157
15. Singh M.M., Gupta D.N., Wadhwa V., Jain G.K., Khanna N.M., and Kamboj V.P. Post-coital contraceptive efficacy and hormonal profile of ferujol: a new coumarin from Ferula jaeschkeana. Planta Medica 51 (1985) 268-270
16. Wadhwa V., Singh M.M., Gupta D.N., Singh C., and Kamboj V.P. Contraceptive and hormonal properties of Achyranthus aspera. Planta Medica 3 (1986) 231-233
17. Keshri G., Lakshmi V., Singh M.M., and Kamboj V.P. Post-coital contraceptive property of Ferula assafoetida Linn. in female rats. Pharmaceut Biol 37 (1999) 273-276
18. Chan R.Y.K., Chen W.F., Dong A., Guo D., and Wong M.S. Estrogen-like activity of Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 87 (2002) 3691-3695
19. Kayisli U.A., Aksu C.A.H., Berkkanoglu M., and Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 87 (2002) 5539-5544
20. Singh M.M., Gupta D.N., Jain G.K., Khanna N.M., and Kamboj V.P. Ferujol. Drugs Fut 11 (1986) 371
21. Singh M.M., Agnihotri A., Garg S.N., et al. Antifertility and hormonal properties of certain carotane sesquiterpenes of Ferula jaeschkeana in rat. Planta Medica 6 (1988) 492-494
22. Srivastava S., Singh M.M., and Kulshreshtha D.K. A new alkaloid and other anti-implantation principles from Tabernaemontana hyneana. Planta Medica 67 (2001) 577-579
23. Kurzer M.S., and Xu X. Dietary phytoestrogens. Ann Rev Nutr 17 (1997) 353-381
24. Cotterchio M., Boucher B.A., Manno M., Gallinger S., Okey A., and Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136 (2006) 3046-3053
25. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Amer J Clin Nutr 76 (2002) 1191-1201
26. Singh M.M., Chauhan S.C., Maitra S.C., Trivedi R.N., and Kamboj V.P. Correlation of pinopod development on uterine luminal epithelial surface with hormonal events and endometrial sensitivity in rat. Eur J Endocr 135 (1996) 107-117
27. Singh M.M., and Booth W.D. Origin of oestrogen in pre-implantation rabbit blastocysts. J Steroid Biochem 11 (1979) 723-728
28. Makker A., and Singh M.M. Endometrial receptivity in relation to fertility, infertility and antifertility: clinical assessment using structural, biochemical and molecular markers. Med Res Rev 26 (2006) 699-746
29. Edgar D.H. Oestrogen and human implantation. Hum Reprod 10 (1995) 2-4
30. Zegers-Hochschild F., and Altieri E. Luteal estrogen is not required for the establishment of pregnancy in the human. J Assist Reprod Genet 12 (1995) 224-228
31. Simon C., Cano F., Valbuena D., Remohi A., and Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod 10 (1995) 2432-2434
32. 2) and progesterone. J Reprod Immunol 39 (1998) 149-166
33. Ng E.H.Y., You W.S.B., Lau E.Y.L., So W.W.K., and Ho P.C. A rapid decline in serum estradiol concentrations around the midluteal phase had no adverse effect on outcome in 763 assisted reproductive cycles. Hum Reprod 15 (2000) 1903-1908
34. Freidler S., Ziemerman A., Schachter M., Raziel A., Strassburger D., and Ron E.I.R. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses. Fertil Steril 83 (2005) 54-60
35. Ma W.-G., Song H., Das S.K., Paria B.C., and Dey S.K. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci 100 (2003) 2963-2968